Last reviewed · How we verify
NCT05739305
Death Certificate Analysis at Colombian Orinoquia: A Retrospective Observational Trial.
trial testing Risk factor in Hospital Mortality in 10,000 participants. Completed in 30 May 2024.
31 December 2023
Quick facts
| Lead sponsor | Hospital Departamental de Villavicencio |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 10,000 |
| Start date | 1 July 2023 |
| Primary completion | 31 December 2023 |
| Estimated completion | 30 May 2024 |
| Sites | 1 location across Colombia |
Drugs / interventions tested
- Risk factor
Conditions studied
- Hospital Mortality — all drugs for Hospital Mortality →
- Cancer — all drugs for Cancer →
- Chronic Disease — all drugs for Chronic Disease →
- Non Communicable Chronic Diseases — all drugs for Non Communicable Chronic Diseases →
Sponsor
Hospital Departamental de Villavicencio
Who can join
Under 120, any sex, with Hospital Mortality or Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
By hospital mortality, the health of a population is identified. Death certificates are a valuable tool in establishing causes of death. The objective will be to analyze the main causes of death in hospitalized patients by population groups of interest. A retrospective observational study will be carried out, by analyzing the death databases of the Hospital Departamental of Villavicencio from January 2012 to May 2022. The records will be exported to Excel for review and debugging. Demographic variables and causes of death will be analyzed. The categorical variables will be described in frequency and proportion; the quantitative ones will be defined in their central distribution and dispersion. For comparison, the Chi-square and Mann-Whitney test will be performed according to the characteristics of the outcome studied. It is expected to identify the main causes of death in the groups of interest (adults, maternal, infants, fetal and non-fetal, congenital malformations) and their characteristics.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05739305
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Risk factor
Trials testing the same drug.
- NCT05954936 — Trauma Registry in Villavicencio, Colombia · completed
Other Hospital Departamental de Villavicencio trials
Trials by the same sponsor.
- NCT07530653 — Delayed Fluids in Hemorrhagic Shock Due to Severe Injuries. · not yet recruiting
- NCT07372092 — Complications of Surgical Geriatrics Hospitalized in the Orinoco Region · not yet recruiting
- NCT07249749 — Factor Associated With Mortality in the ICU · not yet recruiting
- NCT06048575 — Cholecystitis in Villavicencio Hospitals · completed
- NCT05938647 — Severe Dengue in Critical Care at Villavicencio, Colombia. · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05739305 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Departamental de Villavicencio
- Last refreshed: 12 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05739305.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing